Triazolopyridinylsulfanyl compound as p38 MAP kinase inhibitor
PK140712AUndetermined Publication Date: 2010-05-17PFIZER INC
0 Cites 0 Cited by
Patent Information
- Application Number
- PK200500733
- Authority / Receiving Office
- PK · PK
- Patent Type
- Applications
- Current Assignee / Owner
- Publication Date
- 2010-05-17
Abstract
This invention relates to a compound of formula (I): and the use of a compound of formula (I) in the treatment of a TNF-mediated disease, disorder, or condition, or a p38-mediated disease, disorder, or condition, in particular the allergic and non-allergic airways diseases, more particularly obstructive or inflammatory airways diseases, preferably chronic obstructive pulmonary disease.
Need to check novelty before this filing date? Find Prior Art